Literature DB >> 3088823

Effect of EDTA-tris on an Escherichia coli isolate containing R plasmids.

R E Wooley, H W Dickerson, K W Simmons, E B Shotts, J Brown.   

Abstract

Solutions of ethylenediaminetetraacetate (EDTA)-tris combined with antibiotics have been shown to be effective in treating selected cases of persistent bacterial infections. Basic techniques in microbial genetics, including mating frequencies, chemical elimination of R plasmids, isolation of plasmid DNA and agarose gel electrophoresis, were used to determine if EDTA-tris has a curing effect on an R plasmid as part of its clinical action. Results of this study indicated that EDTA-tris by itself eliminated an antibiotic resistance marker from a clinical isolate of Escherichia coli and when combined with another chemical curing agent altered the isolate's mating frequency.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088823     DOI: 10.1016/0378-1135(86)90042-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Comparison of virulence factors and R plasmids of Salmonella spp. isolated from healthy and ill swine.

Authors:  K W Simmons; R E Wooley; J Brown
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

2.  Detection and characterization of Salmonella typhimurium from a dairy herd in North Dakota.

Authors:  L K Nolan; C W Giddings; E W Boland; D J Steffen; J Brown; A Misek
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

3.  Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.

Authors:  Keith Miller; Alexander J O'Neill; Mark H Wilcox; Eileen Ingham; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

4.  Bactericidal efficacy of elevated pH on fish pathogenic and environmental bacteria.

Authors:  Clifford E Starliper; Barnaby J Watten
Journal:  J Adv Res       Date:  2012-08-02       Impact factor: 10.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.